Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Volume 12
Number 2
CURRENT ISSUE
NEXT ISSUE

 
ARTICLE
TYPE
ABSTRACT
PDF
Pages
  CURRENT ISSUE
Discovering new drugs for Hepatocellular Carcinoma?
EDITORIAL
67-72
Beyond Regorafenib for Hepatocellular Carcinoma: Next – generation Perspectives.
NEWS & VIEWS
73-78
RNA-sequencing identifies a new molecular classification of pancreatic cancer: Implications and challenges.
NEWS & VIEWS
79-84
Predicting risk  of disease and therapeutic resistance for patients with Hepatocellular Carcinoma.
View Point
85-90
Predicting the efficacy of novel drugs at early stage of development.
PERSPECTIVE
91-98
Structural genomic alterations, non-coding variants and regulatory networks. The revolution of future in cancer therapy
PERSPECTIVE
99-106
Overcoming challenges of primary liver cancers by integrating Next-Generation Sequencing.
Special Report
107-121

Linear transcription dogma: the standard approach for drug discovery.

REVIEW
122-134
Disrupting transcriptional bio-circuits with next-generation drugs: Realistic or elusive approach?
REVIEW
135-142

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.



Search only trustworthy HONcode health websites:

last update: 31 August 2017